National Vision Holdings Inc. (EYE)
EYE or CL: Which Is the Better Value Stock Right Now?
Investors with an interest in Consumer Products - Staples stocks have likely encountered both National Vision (EYE) and Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?
Has National Vision (EYE) Outpaced Other Consumer Staples Stocks This Year?
Here is how National Vision (EYE) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
How Much Upside is Left in National Vision (EYE)? Wall Street Analysts Think 28.92%
The mean of analysts' price targets for National Vision (EYE) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
EYE vs. CL: Which Stock Is the Better Value Option?
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of National Vision (EYE) and Colgate-Palmolive (CL). But which of these two stocks offers value investors a better bang for their buck right now?
National Vision Holdings: Still Hard To Determine If Turnaround Initiative Will Be Successful
I maintain a hold rating for National Vision Holdings due to uncertainty about whether strategic initiatives will improve fundamentals. EYE's 4Q24 earnings showed 3.9% y/y growth, but profitability remains an issue, with a net loss of $29.4 million. Positive signs include a shift toward managed care customers and store optimizations, but CSSG and profitability need to improve.
National Vision (EYE) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why National Vision (EYE) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges
Continued strength in Managed Care aids National Vision's fourth-quarter 2024 performance.
National Vision Holdings Inc (EYE) Q4 2024 Earnings Call Transcript
National Vision Holdings Inc (NASDAQ:EYE ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Tamara Gonzalez - VP of Investor Relations Reade Fahs - CEO Alex Wilkes - President Melissa Rasmussen - CFO Conference Call Participants Michael Lasser - UBS Anthony Chukumba - Loop Capital Markets Taylor Brimberg - Wells Fargo Simeon Gutman - Morgan Stanley Meghan Holtz - Jefferies Adrienne Yih - Barclays Molly Baum - Bank of America Operator Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 National Vision Holdings Earnings Conference Call.
National Vision (EYE) Reports Q4 Loss
National Vision (EYE) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.02 per share a year ago.
Is it the Right Time to Hold EYE Stock in Your Portfolio Now?
National Vision continues to draw investors' attention with its strategic transformation efforts, while positive industry trends should favor its growth.
Why National Vision (EYE) is Poised to Beat Earnings Estimates Again
National Vision (EYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
